Breaking News

Oxygen Biotherapeutics, Hospira Sign Oxycyte Supply Pact

Oxygen Biotherapeutics, Inc. has reached a development and commercial supply agreement with Hospira's One 2 One Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte, a perfluorocarbon (PFC) therapeutic oxygen carrier.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oxygen Biotherapeutics, Inc. has reached a development and commercial supply agreement with Hospira’s One 2 One Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte, a perfluorocarbon (PFC) therapeutic oxygen carrier. Hospira will formulate, fill, finish and label Oxycyte to meet clinical GMP standards and it will be manufactured at the company’s Clayton, NC facility. “This agreement connects us to a first-tier contract manufacturer and superbl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters